Regeneron Tarrytown Campus, Eastview, Town of Greenburgh, Westchester County, New York, United States
Regeneron Pharmaceuticals
CONFIRMEDDate confidence: CONFIRMEDStated as firmHow firmly the source words the date: confirmed, scheduled, estimated, delayed or unverified.Show all CONFIRMED pins82% CONFIDENCEOverall confidence: 82%How well the pin's source and references back up its dates.Weighted average of how firmly 4 references, the source included, support the pin's start and end times; a reference counts half as much for every 180 days older than the newestShow all pins at 75% confidence or betterRegeneron's[4] PRNewswire release is datelined 'TARRYTOWN, N.Y., Nov. 18, 2011' and FierceBiotech[1] posted it 'Nov 18, 2011 5:56pm'; Wikipedia's[2][3] aflibercept page also dates the approval to November 2011.
On 18 November 2011 the FDA approved Regeneron's EYLEA (aflibercept) Injection for wet age-related macular degeneration, dosed every eight weeks after three monthly injections, in a Priority Review.
1.00
